CDG Petchem Receives 'Sell' Rating from MarketsMOJO

Sep 29 2023 12:00 AM IST
share
Share Via
CDG Petchem, a microcap company in the plastic products industry, has received a 'Sell' rating from MarketsMojo due to its high debt-to-equity ratio and poor long-term growth. The latest quarter also showed a decrease in operating cash flow and net sales. While the stock has some bullish indicators, it is fairly valued and may not be a favorable investment option at this time.
CDG Petchem, a microcap company in the plastic products industry, has recently received a 'Sell' rating from MarketsMOJO on September 29, 2023. This downgrade is due to several factors that indicate a weak long-term fundamental strength for the company.

One of the main concerns is the high debt of CDG Petchem, with a debt-to-equity ratio of 8.64 times. This indicates a heavy reliance on debt financing, which can be risky for the company's financial stability. Additionally, the company has shown poor long-term growth, with net sales decreasing by an annual rate of -0.21% and operating profit remaining stagnant at 0% over the last 5 years.

In the latest quarter, CDG Petchem's operating cash flow was at its lowest at Rs 1.04 crore, and net sales have fallen by -18.03%. These results further support the 'Sell' rating given by MarketsMOJO.

On a positive note, the stock is currently in a mildly bullish range and has shown bullish indicators such as MACD, KST, and OBV. However, with a ROCE of only 4.9, the stock is fairly valued with an enterprise value to capital employed ratio of 1.6. It is also trading at a discount compared to its historical valuations.

Majority shareholders of CDG Petchem are the promoters, which may indicate a lack of interest from other investors. However, the stock has outperformed the market (BSE 500) with a return of 128.17% in the last year, while its profits have increased by 85.6%.

In conclusion, CDG Petchem's recent downgrade to 'Sell' by MarketsMOJO is a result of its high debt, poor long-term growth, and flat results in the latest quarter. While the stock has shown some bullish indicators, it is still fairly valued and may not be a favorable investment option for now.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News